Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

OPPILAN PHARMA LIMITED Active

Scientific & Education


Contact information


Unlock Company Insights Free Access

Get instant access to key company data, decision-maker contacts, and verified insights.

Start for Free now

Financial statements of OPPILAN PHARMA LIMITED

According to OPPILAN PHARMA LIMITED latest financial report submitted on 2023-05-31, the company has a Cash of £562,230.00, Total-Assets of £1M while the Working-Capital is £68M. Compared with the previous year, the company reported a Cash increase of 38.83%, which is an equivalent of -218308. At the same time, the Total-Assets went up by 32.29%, or by -479931.


Year:
2022 Not available
2021 Not available
2020 Not available
2019 Not available

Access 20 Years of Financial Data

Start for free
  • Reporting period

    12

  • Consolidated A/cs

    N

  • Working Capital

    £ 68.3 million

EBITDA

OPPILAN PHARMA LIMITED Business Credit Report

A Business Credit Report for OPPILAN PHARMA LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for OPPILAN PHARMA LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

OPPILAN PHARMA LIMITED

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

OPPILAN PHARMA LIMITED Directors and key executives

OPPILAN PHARMA LIMITED currently employs 2 people. Compared with the previous year, the company has reported a staff increase of 0%, which is an equivalent of 0 employees.
In order to view contact information, including emails and phone numbers for all the employees working at OPPILAN PHARMA LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

2

100%

1y growth

100%

2y growth

Management Level


100

Middle

Employee Job Title Email Phone Country
John Nuss Director
-
- GB
Raju Mohan Director
-
- GB
John Nuss Cso
-
- GB

Get direct emails & phone numbers for senior executives working at «OPPILAN PHARMA LIMITED»

Download our chrome extension and enrich prospect profiles in seconds. Organize contacts into focus lists, send e-mails or embed leads into automated sequences straight off their Linkedin profile - without leaving the browser.

Install Free Browser Extension

OPPILAN PHARMA LIMITED Ownership and Group Structure


Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Start Free Now

OPPILAN PHARMA LIMITED Shareholders and Ultimate Beneficial Owners (UBO)

There are currently 3 people with significant control at OPPILAN PHARMA LIMITED. One of of major shareholders of OPPILAN PHARMA LIMITED is VENTYX BIOSCIENCES INC., which owns 5250000 SERIES A shares, with a total value of 0 None and VENTYX BIOSCIENCES INC., which owns 16500000 SERIES B shares, with a total value of 0 None and VENTYX BIOSCIENCES INC., which owns 4526158 ORDINARY shares, with a total value of 4,526,158 None.


Name Quantity Share Type Value
VENTYX BIOSCIENCES INC.
5250000 SERIES A 0 GBP
VENTYX BIOSCIENCES INC.
16500000 SERIES B 0 GBP
VENTYX BIOSCIENCES INC.
4526158 ORDINARY 4526158 GBP

See All Beneficial Owners & Shareholders

Unlock Full Access For Free

OPPILAN PHARMA LIMITED competitors:

Top 5 similar companies of OPPILAN PHARMA LIMITED are AURELIA BIOSCIENCE LTD, XENOGESIS LIMITED, APITOPE TECHNOLOGY (BRISTOL) LIMITED, IG INNOVATIONS LIMITED, BIODEXA LTD. View and export all the competitor list of OPPILAN PHARMA LIMITED by upgrading your account here.


AURELIA BIOSCIENCE LTD


Revenue
-
Age
14 years
Employees
6
Industry
View Scientific & Education
Website
View https://aure***********

XENOGESIS LIMITED


Revenue
-
Age
14 years
Employees
4
Industry
View Scientific & Education
Website
View https://xeno**********

APITOPE TECHNOLOGY (BRISTOL) LIMITED


Revenue
-
Age
23 years
Employees
1
Industry
View Scientific & Education
Website
View https://api*********

IG INNOVATIONS LIMITED


Revenue
155,000.0
Age
15 years
Employees
5
Industry
View Scientific & Education
Website
View http://ig-innov*************

BIODEXA LTD


Revenue
-
Age
25 years
Employees
4
Industry
View Scientific & Education
Website
View http://midatec************

View & Export OPPILAN PHARMA LIMITED competitors:

Get the complete list with detailed profiles

Start For Free

OPPILAN PHARMA LIMITED news & activities:


EBITDA

The OPPILAN PHARMA LIMITED-based company said the adjusted EBITDA is now £1,276.35, compared with the previous year of -1.

uk.globaldatabase.com

2023-05-31

Employees

OPPILAN PHARMA LIMITED number of employees has decreased by 0% compared with previous year and now represents a total number of 2.

uk.globaldatabase.com

2023-05-31

Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Start For Free

Frequently Asked Questions regarding OPPILAN PHARMA LIMITED


Where is OPPILAN PHARMA LIMITED registered office?

OPPILAN PHARMA LIMITED is located at 5 New Street Square, United Kingdom.

What is the website of OPPILAN PHARMA LIMITED?

OPPILAN PHARMA LIMITED website is http://oppilan.com/

How many people work at OPPILAN PHARMA LIMITED?

According to the latest account statement, there are currently 2 of employees working for OPPILAN PHARMA LIMITED.

What is OPPILAN PHARMA LIMITED EBITDA?

For 2023, OPPILAN PHARMA LIMITED has reported an EBITDA of £1,276.35, which went down by -100.06% compared to previous year.

What is the Business Credit Score of OPPILAN PHARMA LIMITED and how reliable is the company?

In order to check the business credit score of OPPILAN PHARMA LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does OPPILAN PHARMA LIMITED pay their invoices on time?

By requesting a Business Credit Report for OPPILAN PHARMA LIMITED, you will be able to gain more insights about the OPPILAN PHARMA LIMITED payment trends.

Who is the Ultimate Parent of the OPPILAN PHARMA LIMITED?

Information about the ultimate beneficial ownership VENTYX BIOSC********** of OPPILAN PHARMA LIMITED is available when you order a business credit report.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Get Free API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action